About
Eye-Tracking Technology
Areas of Focus
Categories
Uncategorized Medical Device
Team (18)
Alexandre Drouin-Picaro, M.Sc., Soft. Eng.
Vice President, AI Research & Development (Founding member)
Innodem Neurosciences
executive
Daniel E. Guitton
Ph.D. – Oculomotor Control Expert
Innodem Neurosciences
team_member
Dr. Angela Genge
MD, FRCPC(C) – ALS
Innodem Neurosciences
team_member
Dr. Edward A. Fon
MD, FRCP(C) – Parkinson’s
Innodem Neurosciences
team_member
Dr. Jack Antel
MD, FRCP(C) –Multiple Sclerosis
Innodem Neurosciences
team_member
Dr. Simon Ducharme
M.D., CM, FRCPC(C) - Alzheimer
Innodem Neurosciences
team_member
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
1,348
By Status
RECRUITING: 6NOT_YET_RECRUITING: 1SUSPENDED: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06283524Lead Sponsor
Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis
N/ANot yet recruiting
100 participants
Started: Mar 18, 2024 · Completed: Mar 18, 2026
NCT06256731Lead Sponsor
ETNA-MS Device Validation Study
N/ARecruiting
60 participants
Started: Dec 12, 2023 · Completed: Jun 12, 2024
NCT05661266Lead Sponsor
Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis
N/ARecruiting
120 participants
Started: Aug 16, 2023 · Completed: Apr 30, 2025
NCT05277740Collaborator
Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis
N/ARecruiting
120 participants
Started: Sep 1, 2022 · Completed: Jul 31, 2024
NCT05176704Lead Sponsor
Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease
N/ARecruiting
250 participants
Started: Apr 15, 2022 · Completed: Mar 3, 2024
Locations (1)
Headquarters
Montréal, QC, Canada
Map
Loading map...